Role of anti-oncomirs miR-143 and -145 in human colorectal tumors (original) (raw)

Cancer Gene Therapy volume 17, pages 398–408 (2010)Cite this article

Subjects

Abstract

We examined the expression levels of microRNAs (miRNAs (miRs)) in colorectal tumors (63 cancer specimens and 65 adenoma specimens) and paired non-tumorous tissues. Decreased expression of miR-143 and -145 was frequently observed in the adenomas and cancers tested, compared with miR-34a downregulation and miR-21 upregulation. Expression profiles of miR-143 and -145 were not associated with any clinical features. As the downregulation of miR-143 and -145 was observed even in the early phase of adenoma formation, the decreased expression of both miRs would appear to contribute mainly to the initiation step of tumorigenesis, not to the progression stage, and not to clinical prognostic factors. For clinical application, we changed the sequences of the passenger strand in the miR-143 duplex and performed chemical modification at the 3′-overhang portion of miR-143, leading to greater activity and stability to nuclease. The cell growth inhibitory effect of the chemically modified synthetic miR-143 in vitro was greater than that of endogenous miR-143. The miR-143 showed a significant tumor-suppressive effect on xenografted tumors of DLD-1 human colorectal cancer cells. These findings suggest that miR-143 and -145 are important onco-related genes for the initiation step of colorectal tumor development and that the chemically modified synthetic miR-143 may be a hopeful candidate as an RNA medicine for the treatment of colorectal tumors.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Kloosterman WP, Plasterk RH . The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441–450.
    Article CAS PubMed Google Scholar
  2. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 2004; 101: 2999–3004.
    Article CAS PubMed PubMed Central Google Scholar
  3. Croce CM, Calin GA . miRNAs, cancer, and stem cell division. Cell 2005; 122: 6–7.
    Article CAS PubMed Google Scholar
  4. Gregory RI, Shiekhattar R . MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509–3512.
    Article CAS PubMed Google Scholar
  5. Eder M, Scherr M . MicroRNA and lung cancer. N Engl J Med 2005; 352: 2446–2448.
    Article CAS PubMed Google Scholar
  6. McManus MT . MicroRNAs and cancer. Semin Cancer Biol 2003; 13: 253–258.
    Article CAS PubMed Google Scholar
  7. Akao Y, Nakagawa Y, Naoe T . MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006; 16: 845–850.
    CAS PubMed Google Scholar
  8. Akao Y, Nakagawa Y, Naoe T . MicroRNA-143 and -145 in colon cancer. DNA Cell Biol 2007; 26: 311–320.
    Article CAS PubMed Google Scholar
  9. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y . Decreased expression of microRNAs-143 and -145 in human gastric cancers. Oncology 2009; 77: 12–21.
    Article CAS PubMed Google Scholar
  10. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T . Down-regulation of micoRNAs-143 and -145 in B-cell malignancies. Cancer Sci 2007; 98: 1914–1920.
    Article CAS PubMed Google Scholar
  11. Akao Y, Nakagawa Y, Iio A, Naoe T . Role of microRNA-143 in Fas-mediated apoptosis in human leukemia Jurkat cells. Leuk Res 2009; 33: 1530–1538.
    Article CAS PubMed Google Scholar
  12. Behlke MA . Progress towards in vivo use of siRNAs. Mol Ther 2006; 13: 644–670.
    Article CAS PubMed Google Scholar
  13. Ueno Y, Inoue T, Yoshida M, Yoshikawa K, Shibata A, Kitamura Y et al. Synthesis of nuclease-resistant siRNAs possessing benzen-phosphate backbones in their 3′-overhang regions. Bioor Med Chem Lett 2008; 18: 5194–5196.
    Article CAS Google Scholar
  14. Ueno Y, Kato T, Sato K, Ito Y, Inoue T, Shibata A et al. Synthesis and properties of nucleic acid analogues consisting of a benzene-phosphate backbone. J Org Chem 2005; 70: 7925–7935.
    Article CAS PubMed Google Scholar
  15. Akao Y, Itoh T, Ohguchi K, Iinuma M, Nozawa Y . Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg Med Chem 2008; 16: 2803–2810.
    Article CAS PubMed Google Scholar
  16. Shin C . Cleavage of the star strand facilitates assembly of some microRNAs into Ago2-containing silencing complexes in mammals. Mol Cells 2008; 26: 308–313.
    CAS PubMed Google Scholar
  17. Lingel A, Simon B, Izaurralde E, Sattler M . Structure and nucleic-acid binding of the Drosophila Argonaute 2 PAZ domain. Nature 2003; 426: 465–469.
    Article CAS PubMed Google Scholar
  18. Yan KS, Yan S, Farooq A, Han A, Zeng L, Zhou MM . Structure and conserved RNA binding of the PAZ domain. Nature 2003; 426: 468–474.
    Article PubMed Google Scholar
  19. Ma JB, Ye K, Patel DJ . Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain. Nature 2004; 428: 318–322.
    Article Google Scholar
  20. Michael MZ, O’ Connor SM, van Holst Pellekaan NG, Yang GP, James RJ . Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 2003; 1: 882–891.
    CAS PubMed Google Scholar
  21. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, Bednarikova M et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007; 72: 397–402.
    Article CAS PubMed Google Scholar
  22. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008; 299: 425–436.
    CAS PubMed PubMed Central Google Scholar
  23. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, Ravichandran LV et al. MicroRNA-143 regulates adipocyte differentiation. J Biol Chem 2004; 279: 52361–52365.
    Article CAS PubMed Google Scholar
  24. Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y et al. Role of miRNA-143 targeting KRAS in colorectal tumorigenesis. Oncogene 2009; 28: 1385–1392.
    Article CAS PubMed Google Scholar
  25. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD . Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003; 115: 199–208.
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

We thank Dr Takagi, Dr Tanigawa (Osaka Medical College Hospital), Dr Takagi (Kyouritsu General Hospital), Dr Takahama, Dr Watanabe, Dr Iwata, Dr Kamiya, Dr Maruyama, Dr Shibata, Dr Kamano and Dr Ohkubo (Fujita Health University Hospital) for supplying samples. This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Gifu International Institute of Biotechnology, Kakamigahara, Gifu, Japan
    Y Akao, A Iio, T Itoh & K Kojima
  2. Department of Gastroenterology, Fujita Health University, School of Medicine, Kutsukake-cho, Toyoake, Aichi, Japan
    Y Nakagawa & I Hirata
  3. Department of Biomolecular Science, Faculty of Engineering, Gifu University, Yanagido, Gifu, Japan
    R Nakashima & Y Kitade
  4. United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Yanagido, Gifu, Japan
    Y Akao & Y Kitade
  5. Department of Hematology and Oncology, Nagoya University, Graduate School of Medicine, Showa-ku, Nagoya, Japan
    T Naoe

Authors

  1. Y Akao
    You can also search for this author inPubMed Google Scholar
  2. Y Nakagawa
    You can also search for this author inPubMed Google Scholar
  3. I Hirata
    You can also search for this author inPubMed Google Scholar
  4. A Iio
    You can also search for this author inPubMed Google Scholar
  5. T Itoh
    You can also search for this author inPubMed Google Scholar
  6. K Kojima
    You can also search for this author inPubMed Google Scholar
  7. R Nakashima
    You can also search for this author inPubMed Google Scholar
  8. Y Kitade
    You can also search for this author inPubMed Google Scholar
  9. T Naoe
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toY Akao.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

About this article

Cite this article

Akao, Y., Nakagawa, Y., Hirata, I. et al. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors.Cancer Gene Ther 17, 398–408 (2010). https://doi.org/10.1038/cgt.2009.88

Download citation

Keywords